UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000049486
Receipt number R000056353
Scientific Title Pilot Randomized Controlled Trial of Occupation-Based Intervention for Patients with Brain Tumors
Date of disclosure of the study information 2022/11/15
Last modified on 2023/01/08 22:14:55

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Pilot Randomized Controlled Trial of Occupation-Based Intervention for Patients with Brain Tumors

Acronym

Pilot Randomized Controlled Trial of Occupation-Based Intervention for Patients with Brain Tumors

Scientific Title

Pilot Randomized Controlled Trial of Occupation-Based Intervention for Patients with Brain Tumors

Scientific Title:Acronym

Pilot Randomized Controlled Trial of Occupation-Based Intervention for Patients with Brain Tumors

Region

Japan


Condition

Condition

Brain Tumor

Classification by specialty

Rehabilitation medicine

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

The purpose of this study is to investigate whether occupational therapy based on OBI is effective in maintaining and improving the quality of life of patients with brain tumors.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

the european organization for research and treatment of cancer qlq-c30

Key secondary outcomes

Physical function: Brunnstrom stage (Brs)
Walking ability: 10m walking speed. timed up and go test (TUG)
Hand grip (HG)
Knee extension muscle strength: Hand held dynamometer (HHD)
Cognitive function: Mini Mental State Examination (MMSE-J), Trail Making Test Japan version (TMT-J)
ADL ability: Functional independence measure (FIM), Barthel index (BI)
Mental function: Hospital Anxiety and Depression Scale (HADS)
IADL: Frenchay Activities Index (FAI)
Activity: International Physical Activity Questionnaire (IPAQ)
Work satisfaction and performance: Assistive Decision Making Software for Selecting Tasks (ADOC)


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Cluster

Blinding

Open -no one is blinded

Control

Active

Stratification

NO

Dynamic allocation

NO

Institution consideration

Institution is not considered as adjustment factor.

Blocking

NO

Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Other

Interventions/Control_1

The OBI group will use ADOC to set clear goals and implement a work-based intervention. Two-thirds of the intervention will be meaningful work based on life history, and one-third will be functional practice.The frequency of intervention will be five times a week for both interventions.

Interventions/Control_2

In the IBI group, goal-setting tools such as ADOC and Canadian Occupational Performance Measure are not used, two-thirds of the patients perform functional exercises, and one-third perform ADL/Instrumental Activities of Daily Living exercises.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

80 years-old >

Gender

Male and Female

Key inclusion criteria

Patients who have given consent to participate in this study. Patients diagnosed with brain tumors. Patients who have undergone rehabilitation intervention after brain tumor resection, are at least 20 years old, and have a MMSE-J score of 24 or higher.

Key exclusion criteria

Patients with a history of congenital disorders or diseases of the central nervous system, MMSE-J score of 23 or less. Cases in which the patient's consent could not be obtained. Other cases in which the principal investigator determines that the subject is not suitable for the study.

Target sample size

80


Research contact person

Name of lead principal investigator

1st name syun
Middle name
Last name ito

Organization

Shinshu University Hospital

Division name

Rehabilitation Department

Zip code

390-8621

Address

3-1-1 Asahi, Matsumoto, Nagano

TEL

0263-37-2836

Email

itosyun@shinshu-u.ac.jp


Public contact

Name of contact person

1st name syun
Middle name
Last name ito

Organization

Shinshu University Hospital

Division name

Rehabilitation Department

Zip code

390-8621

Address

3-1-1 Asahi, Matsumoto, Nagano

TEL

0263-37-2836

Homepage URL


Email

itosyun@shinshu-u.ac.jp


Sponsor or person

Institute

Shinshu University Hospital

Institute

Department

Personal name



Funding Source

Organization

Japan Science and Technology Agency

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Shinshu University Hospital

Address

3-1-1 Asahi, Matsumoto, Nagano

Tel

0263-37-2836

Email

itosyun@shinshu-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2022 Year 11 Month 15 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2022 Year 11 Month 13 Day

Date of IRB

2022 Year 11 Month 18 Day

Anticipated trial start date

2022 Year 11 Month 30 Day

Last follow-up date

2025 Year 01 Month 31 Day

Date of closure to data entry

2025 Year 01 Month 31 Day

Date trial data considered complete

2025 Year 03 Month 31 Day

Date analysis concluded

2025 Year 03 Month 31 Day


Other

Other related information



Management information

Registered date

2022 Year 11 Month 13 Day

Last modified on

2023 Year 01 Month 08 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000056353